UBS Group AG

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in ARQT

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$78,436,516

-$15,752,748 QoQ

Shares Held

3,329,224

+2.6% QoQ

Ownership

2.66%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

24 quarters on record

Voting authority Sole 99.58191458429953.ToString("F0")% Shared 0.ToString("F0")% None 0.4180854157004756.ToString("F0")%

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,296,969,172 across 554 Biotechnology names. ARQT ranks #28 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	22,619,472	$626,559,372
2	PTGX	Protagonist Therapeutics, Inc	5,177,796	$545,739,697
3	ABVX	Abivax S.A.	4,547,406	$506,353,656
4	RVMD	Revolution Medicines, Inc.	4,386,791	$426,615,424
5	INSM	INSMED Inc	1,737,481	$284,112,890
6	VRTX	Vertex Pharmaceuticals Inc / Ma	630,618	$281,596,158
7	APLS	Apellis Pharmaceuticals, Inc.	6,206,681	$249,694,775
8	REGN	Regeneron Pharmaceuticals, Inc.	299,979	$231,775,770

24 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$78,436,516	3,329,224	+2.6%	Shares	Defined	2026-05-05
2025-12-31	$94,189,264	3,243,432	+10.0%	Shares	Defined	2026-01-29
2025-09-30	$55,578,055	2,948,438	+0.4%	Shares	Defined	2025-11-13
2025-06-30	$41,189,904	2,937,939	+0.6%	Shares	Defined	2025-08-14
2025-03-31	$45,668,924	2,920,008	+4.7%	Shares	Defined	2025-05-13
2024-12-31	$38,858,152	2,789,530	+1166.9%	Shares	Sole	2025-02-14
2024-09-30	$2,047,803	220,194	-28.9%	Shares	Defined	2024-11-14
2024-06-30	$2,879,010	309,571	-36.9%	Shares	Sole	2024-08-14
2024-03-31	$4,862,609	490,677	+23265.6%	Shares	Sole	2024-05-13
2023-12-31	$6,783	2,100	-96.7%	Shares	Defined	2024-02-09
2023-09-30	$340,594	64,142	-54.1%	Shares	Sole	2023-11-09
2023-06-30	$1,331,836	139,752	+57.4%	Shares	Sole	2023-08-11
2023-03-31	$976,569	88,779	-54.1%	Shares	Defined	2023-05-12
2022-12-31	$2,861,002	193,311	+720.1%	Shares	Sole	2023-02-08
2022-09-30	$450,459	23,572	+41.0%	Shares	Defined	2022-11-10
2022-06-30	$356,280	16,719	-69.2%	Shares	Defined	2022-08-10
2022-03-31	$1,045,856	54,302	-0.7%	Shares	Sole	2022-05-16
2021-12-31	$1,133,709	54,663	+81.3%	Shares	Sole	2022-02-14
2021-09-30	$720,402	30,155	+167.1%	Shares	Defined	2021-11-15
2021-06-30	$308,103	11,290	-44.8%	Shares	Defined	2021-08-13
2021-03-31	$591,501	20,446	+3235.4%	Shares	Defined	2021-05-12
2020-09-30	$17,960	613	-80.3%	Shares	Sole	2020-11-12
2020-06-30	$94,046	3,110	-51.9%	Shares	Sole	2020-07-31
2020-03-31	$192,746	6,468	—	Shares	Sole	2020-05-01
No filing history on record for this holder in this stock.